Paraneoplastic pemphigus sera react strongly with multiple epitopes on the various regions of envoplakin and periplakin, except for the c-terminal homologous domain of periplakin.
Paraneoplastic pemphigus sera react with multiple plakin family proteins, among which only envoplakin and periplakin are constantly detected by immunoblotting using normal human epidermal extracts. Using bacterial expression vectors containing polymerase chain reaction-amplified cDNA, we have prepared variously truncated recombinant glutathione-S-transferase-fusion proteins of envoplakin and periplakin, which presented N-terminal, central and C-terminal domains of each protein, as well as the so-called C-terminal homologous domain of envoplakin and the junctional regions of these domains. By immunoblotting using these 11 recombinant proteins, we demonstrated that most of the 26 paraneoplastic pemphigus sera reacted very strongly with multiple recombinant proteins of envoplakin and periplakin, except for the C-terminal homologous domain of periplakin. We also examined the reactivity with these recombinant proteins of other blistering diseases, including pemphigus vulgaris, pemphigus foliaceus, and bullous pemphigoid, and found that a few nonparaneoplastic pemphigus sera showed a weak reactivity with some of the recombinant proteins. Interestingly, some sera showed relatively strong reactivity with the C-terminal homologous domain of periplakin to which paraneoplastic pemphigus sera reacted less frequently. These results indicate that, although nonparaneoplastic pemphigus sera occasionally show a weak reactivity with envoplakin and periplakin, the pathogenicity and the mechanism of antibody production in these cases may be different from those in paraneoplastic pemphigus.
Nagata
Y
Y
Department of Dermatology, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Karashima
T
T
Watt
F M
FM
Salmhofer
W
W
Kanzaki
T
T
Hashimoto
T
T
D001327:Autoimmune Diseases / Q000097:blood; D001769:Blood / Q000276:immunology; D003598:Cytoskeletal Proteins / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D004817:Epidermis / Q000737:chemistry; D000939:Epitopes / Q000276:immunology*; D006801:Humans; D015151:Immunoblotting; D008565:Membrane Proteins / Q000235:genetics / Q000276:immunology*; D010257:Paraneoplastic Syndromes / Q000097:blood*; D010392:Pemphigus / Q000097:blood*; D051179:Plakins; D011233:Precipitin Tests; D011498:Protein Precursors / Q000235:genetics / Q000276:immunology*; D017434:Protein Structure, Tertiary / Q000502:physiology; D011993:Recombinant Fusion Proteins / Q000276:immunology; D012872:Skin Diseases, Vesiculobullous / Q000097:blood; D014020:Tissue Extracts / Q000276:immunology
D003598:Cytoskeletal Proteins; D000939:Epitopes; D008565:Membrane Proteins; C491674:PPL protein, human; D051179:Plakins; D011498:Protein Precursors; D011993:Recombinant Fusion Proteins; D014020:Tissue Extracts; C100754:envoplakin